Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (261-270 of 539) with videos related to

Pageof 54
Sort By:
British Journal of Haematology|March 19, 2016
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myelomaJens Hillengass, Judith Ritsch, Maximilian Merz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myelomaJens Hillengass, Kerstin Fechtner, Marc-André Weber, et al.
Cancer Genetics and Cytogenetics|August 17, 2005
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISHFriedrich W Cremer, Mutlu Kartal, Dirk Hose, et al.
European Journal of Haematology|March 28, 2008
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myelomaSebastian Belle, Fang Han, Maud Condomines, et al.
Cancers|March 6, 2021
Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression PatternsMarkus Wennmann, Thomas Hielscher, Laurent Kintzelé, et al.
Blood|March 7, 2007
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myelomaKarène Mahtouk, Dirk Hose, Pierre Raynaud, et al.
Haematologica|July 21, 2007
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized studyJean-Henri Bourhis, Yasmina Bouko, Serge Koscielny, et al.
European Radiology|January 16, 2016
Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biologyElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Blood|September 2, 2006
CD200 is a new prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Thierry Reme, et al.
Journal of Surgical Oncology|October 1, 2011
Kyphoplasty in patients with multiple myeloma a retrospective comparative pilot studyChristian Kasperk, Andreas Haas, Jens Hillengass, et al.
Pageof 54

Showing results (261-270 of 539) with videos related to

Sort By:
Pageof 54
British Journal of Haematology|March 19, 2016
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myelomaJens Hillengass, Judith Ritsch, Maximilian Merz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myelomaJens Hillengass, Kerstin Fechtner, Marc-André Weber, et al.
Cancer Genetics and Cytogenetics|August 17, 2005
High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISHFriedrich W Cremer, Mutlu Kartal, Dirk Hose, et al.
European Journal of Haematology|March 28, 2008
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myelomaSebastian Belle, Fang Han, Maud Condomines, et al.
Cancers|March 6, 2021
Analyzing Longitudinal wb-MRI Data and Clinical Course in a Cohort of Former Smoldering Multiple Myeloma Patients: Connections between MRI Findings and Clinical Progression PatternsMarkus Wennmann, Thomas Hielscher, Laurent Kintzelé, et al.
Blood|March 7, 2007
Heparanase influences expression and shedding of syndecan-1, and its expression by the bone marrow environment is a bad prognostic factor in multiple myelomaKarène Mahtouk, Dirk Hose, Pierre Raynaud, et al.
Haematologica|July 21, 2007
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized studyJean-Henri Bourhis, Yasmina Bouko, Serge Koscielny, et al.
European Radiology|January 16, 2016
Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biologyElias K Mai, Thomas Hielscher, Jost K Kloth, et al.
Blood|September 2, 2006
CD200 is a new prognostic factor in multiple myelomaJerome Moreaux, Dirk Hose, Thierry Reme, et al.
Journal of Surgical Oncology|October 1, 2011
Kyphoplasty in patients with multiple myeloma a retrospective comparative pilot studyChristian Kasperk, Andreas Haas, Jens Hillengass, et al.
Pageof 54